We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




A Sweat-Based On-Site Immunoassay for Monitoring Marijuana Use

By LabMedica International staff writers
Posted on 16 Jan 2020
A novel sweat-based skin test enables on-site testing for tetrahydrocannabinol (THC), the main psychoactive component found in marijuana plants (Cannabis).

This development was made in response to the increase in the number of states legalizing marijuana. More...
This has left law enforcement in a situation where the use and consumption of the drug are legal, but there are no limitations for what is acceptable for driving or operating machinery. The prototype THC detector anticipates the formulation of laws restricting THC consumption by drivers and the need for the police to be able to detect abuse of the substance.

Investigators at University at Albany, State University of New York (USA) had already developed a sweat-based device for measurement of alcohol in the blood. The new device operates in a similar fashion but displays a color change when THC interacts with a specific antibody.

In the new assay system, the THC metabolite and an enzyme-labeled conjugate compete against each other as the antigens for the system. The antibody used in this assay has a greater affinity for the metabolite; so as its concentration increases, the absorbance of the system decreases due to reduced binding of the enzyme-labeled conjugate. Thus, the presence of THC in the sample inhibits the color change generated by the test, and the greater the amount of THC metabolite present in the sweat sample, the less color is produced by the test reagents.

“Currently there is a zero-tolerance policy when it comes to marijuana use and operating machinery,” said senior author Dr Jan Halámek, assistant professor of chemistry at the University at Albany. “While many states are moving to various stages of legalization, the focus is mostly on possession and in-home use. There are no reliable roadside devices being used to test for marijuana-impaired driving. What makes the use of sweat as a biometric unique is that it is non-invasive. No blood needs to be drawn for a sample. Our test can be done instantaneously, on the side of the road, which eliminates any possibility of tampering.”

“While drugs are a new topic for the Halámek lab, it is something we plan to continue diving into,” said Dr. Halámek. “Much of the fundamentals are the same as our previous research in terms of the collection, extraction, and use of sweat as a biometric.”

The THC sweat-based assay was described in the December 3, 2019, online edition of the journal ACS Sensors.

Related Links:
University at Albany, State University of New York


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Automated Staining Unit
RAL Stainer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.